Funding for this research was provided by:
Received: 4 September 2018
Accepted: 26 August 2019
First Online: 14 September 2019
Compliance with ethical standards
: The authors report no other conflicts of interest in this work.
: This study was supported by Merck & Co., Inc. S Kachroo, C Black, and R Borse are employees of Merck & Co., Kenilworth, NJ, USA, and hold stock and options. A Svedbom, J Dalén, M Ivergård, and K Luttropp were paid consultants to Merck through their employment at ICON Clinical Research. ICON Clinical Research has received funding from several pharmaceutical companies involved in the marketing of products for treatment of rheumatic disease.
: This study was supported by Merck & Co., Inc. Given that the work relies on synthesis of publically available data, the research did not involve human participants and/or animals.